tiprankstipranks
Trending News
More News >
Amylyx Pharmaceuticals Inc (AMLX)
NASDAQ:AMLX
US Market
Advertisement

Amylyx Pharmaceuticals Inc (AMLX) Drug Pipeline

Compare
641 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Avexitide
Post Bariatric Hypoglycemia
Phase III
Recruiting
Avexitide for Treatment of Post-Bariatric Hypoglycemia
Dec 18, 2024
Amx0114
Als
Phase I
Recruiting
AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis
Oct 25, 2024
Amx0035
Neurodegenerative Diseases, Progressive Supranuclear Palsy, Psp, Atypical Parkinsonism
Phase II/III
Active Not Recruiting
AMX0035 and Progressive Supranuclear Palsy
Nov 03, 2023
Amx0035
Wolfram Syndrome
Phase II
Active Not Recruiting
AMX0035 in Adult Patients With Wolfram Syndrome
Dec 22, 2022
Amx0035
Amyotrophic Lateral Sclerosis
Phase III
Completed
Extension Study Evaluating The Safety And Tolerability of AMX0035
Oct 27, 2022
Amx0035
Alzheimer Disease
Phase II
Completed
Study to Assess the Safety and Biological Activity of AMX0035 for the Treatment of Alzheimer's Disease
Apr 30, 2018
Amx0035
Amyotrophic Lateral Sclerosis, Als
Phase II
Completed
Open Label Extension Study of AMX0035 in Patients With ALS
Mar 23, 2018

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Amylyx Pharmaceuticals Inc (AMLX) have in its pipeline
      AMLX is currently developing the following drugs: Avexitide, Amx0114, Amx0035. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis